{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06384547",
            "orgStudyIdInfo": {
                "id": "VRDN-001-303"
            },
            "organization": {
                "fullName": "Viridian Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)",
            "officialTitle": "A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants With Thyroid Eye Disease (TED)",
            "acronym": "STRIVE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-randomized-active-controlled-safety-and-tolerability-study-of-vrdn-in-participants-with-thyroid-eye-disease-ted"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-22",
            "studyFirstSubmitQcDate": "2024-04-22",
            "studyFirstPostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Viridian Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-1 receptor (IGF-1R). Inhibition of IGF-1R may help to reduce the inflammation and associated tissue swelling that occurs in patients with thyroid eye disease (TED). The primary objective of this clinical trial is to evaluate the safety and tolerability of VRDN-001 in patients with TED.",
            "detailedDescription": "A randomized, active controlled, safety and tolerability study of VRDN-001, a humanized monoclonal antibody directed against the IGF-1 receptor, in participants with thyroid eye disease (TED)"
        },
        "conditionsModule": {
            "conditions": [
                "Thyroid Eye Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "A randomized, active controlled, safety and tolerability study of VRDN-001, a humanized monoclonal antibody directed against the IGF-1 receptor, in participants with thyroid eye disease (TED)",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 212,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "VRDN-001 10 mg/kg",
                    "type": "EXPERIMENTAL",
                    "description": "5 infusions of VRDN-001 10 mg/kg",
                    "interventionNames": [
                        "Drug: VRDN-001 10 mg/kg"
                    ]
                },
                {
                    "label": "5 infusions of VRDN-001 3 mg/kg",
                    "type": "EXPERIMENTAL",
                    "description": "5 infusions of VRDN-001 3 mg/kg",
                    "interventionNames": [
                        "Drug: VRDN-001 3 mg/kg"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VRDN-001 10 mg/kg",
                    "description": "5 infusions of VRDN-001 10 mg/kg",
                    "armGroupLabels": [
                        "VRDN-001 10 mg/kg"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "VRDN-001 3 mg/kg",
                    "description": "5 infusions of VRDN-001 3 mg/kg",
                    "armGroupLabels": [
                        "5 infusions of VRDN-001 3 mg/kg"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Treatment Emergent Adverse Event (TEAE) incidence rate",
                    "timeFrame": "Week 52"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in proptosis in the study eye as measured by exophthalmometer at Week 15",
                    "timeFrame": "Week 15"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have a clinical diagnosis of TED with or without proptosis and with any CAS (0 - 7) and in the opinion of the investigator may benefit from treatment\n* Must agree to use highly effective contraception method as specified in the protocol\n* Female TED participants must have a negative serum pregnancy test\n\nExclusion Criteria:\n\n* Must not have received prior treatment with another anti-IGF-1R therapy or any investigational agent for TED\n* Must not have used systemic corticosteroids within 2 weeks prior to Day 1\n* Must not have received rituximab, tocilizumab or other immunosuppressive agents within 8 weeks prior to Day 1\n* Must not have received any other therapy for TED within 8 weeks prior to Day 1\n* Must not have a pre-existing ophthalmic condition in the study eye that in the opinion of the Investigator would confound interpretation of the study results\n* Must not have had previous orbital irradiation or decompression surgery involving excision of fat for TED in the study eye's orbit\n* Must not have inflammatory bowel disease\n* Must not have a history or screening audiometry assessment of significant (as determined by investigator) ear pathology, relevant ear surgery, or hearing loss\n* Must not have received an investigational agent for any condition within 8 weeks prior to Day 1\n* Female TED participants must not be pregnant or lactating",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "United Medical Research Institute",
                    "status": "RECRUITING",
                    "city": "Inglewood",
                    "state": "California",
                    "zip": "90301",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Coordinator",
                            "role": "CONTACT",
                            "phone": "310-645-4673"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.96168,
                        "lon": -118.35313
                    }
                },
                {
                    "facility": "Central Coast Retina",
                    "status": "RECRUITING",
                    "city": "Santa Maria",
                    "state": "California",
                    "zip": "93454",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Coordinator",
                            "role": "CONTACT",
                            "phone": "805-876-3050"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.95303,
                        "lon": -120.43572
                    }
                },
                {
                    "facility": "Med-Care Research Corp.",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33125",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Coordinator",
                            "role": "CONTACT",
                            "phone": "786-534-3806"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000049970",
                    "term": "Graves Ophthalmopathy"
                },
                {
                    "id": "D000013959",
                    "term": "Thyroid Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000015785",
                    "term": "Eye Diseases, Hereditary"
                },
                {
                    "id": "D000006111",
                    "term": "Graves Disease"
                },
                {
                    "id": "D000005094",
                    "term": "Exophthalmos"
                },
                {
                    "id": "D000009916",
                    "term": "Orbital Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000006042",
                    "term": "Goiter"
                },
                {
                    "id": "D000006980",
                    "term": "Hyperthyroidism"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16718",
                    "name": "Thyroid Diseases",
                    "asFound": "Thyroid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "asFound": "Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26148",
                    "name": "Graves Ophthalmopathy",
                    "asFound": "Thyroid Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18339",
                    "name": "Eye Diseases, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9214",
                    "name": "Graves Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M8237",
                    "name": "Exophthalmos",
                    "relevance": "LOW"
                },
                {
                    "id": "M12845",
                    "name": "Orbital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M9147",
                    "name": "Goiter",
                    "relevance": "LOW"
                },
                {
                    "id": "M10031",
                    "name": "Hyperthyroidism",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}